professor

research

publication

members

lecture

 

 


1.     Peroxisome Proliferator-Activated Receptor {gamma} Agonist Down-Regulates IL-17 Expression in a Murine Model of Allergic Airway Inflammation.

J Immunol. 2009 Jul 29. [Epub ahead of print]

 

2.    Bax inhibitor-1 overexpression reduces the suppressive effect of calcium mobilizing agent on adipogenesis.

Int J Biochem Cell Biol. 2009 Aug-Sep;41(8-9):1739-45. Epub 2009 Mar 28.

 

3.    Bax inhibitor 1 regulates ER-stress-induced ROS accumulation through the regulation of cytochrome P450 2E1.

J Cell Sci. 2009 Apr 15;122(Pt 8):1126-33.

 

4.    Ca2+/H+ antiporter-like activity of human recombinant Bax inhibitor-1 reconstituted into liposomes.

FEBS J. 2009 Apr;276(8):2285-91. Epub 2009 Mar 5.

 

5.    Refolding and reconstitution of human recombinant Bax inhibitor-1 into liposomes from inclusion bodies expressed in Escherichia coli.

Protein Expr Purif. 2009 Jul;66(1):35-8. Epub 2009 Jan 22.

 

6.    Acidic pH environments increase the expression of cathepsin B in osteoblasts: The significance of ER stress in bone physiology.

Immunopharmacol Immunotoxicol. 2009 Feb 27:1-4. [Epub ahead of print]

 

7.    Adrenomedullin inhibits MAPK pathway-dependent rheumatoid synovial fibroblast-mediated osteoclastogenesis by IL-1 and TNF-alpha.

Bosellia serrata-induced apoptosis is related with ER stress and calcium release.

Genes Nutr. 2008 Feb;2(4):371-4.

 

8.    Lysophosphatidylserine-induced functional switch of human cytochrome P450 1A2 and 2E1 from monooxygenase to phospholipase D.

Biochem Biophys Res Commun. 2008 Nov 21;376(3):584-9. Epub 2008 Sep 16.

 

9.    Protection of cardiomyocytes from ischemic/hypoxic cell death via Drbp1 and pMe2GlyDH in cardio-specific ARC transgenic mice.

J Biol Chem. 2008 Nov 7;283(45):30707-14. Epub 2008 Sep 9.

 

10. CO and bilirubin inhibit doxorubicin-induced cardiac cell death.

Immunopharmacol Immunotoxicol. 2009;31(1):64-70.

 

11. The correlation of Salvia miltiorrhiza extract-induced regulation of osteoclastogenesis with the amount of components tanshinone I, tanshinone IIA, cryptotanshinone, and dihydrotanshinone.

Immunopharmacol Immunotoxicol. 2008;30(2):347-64.

:

12. Effect of ginseng mixture on osteoporosis in ovariectomized rats.

Immunopharmacol Immunotoxicol. 2008;30(2):333-45.

 

13. Kaempferol protects ischemia/reperfusion-induced cardiac damage through the regulation of endoplasmic reticulum stress.

Immunopharmacol Immunotoxicol. 2008;30(2):257-70.

 

14. Anionic phospholipid-induced regulation of reactive oxygen species production by human cytochrome P450 2E1.

FEBS Lett. 2008 May 28;582(12):1771-6. Epub 2008 May 8.

 

15. Bax Inhibitor-1 Is a pH-dependent regulator of Ca2+ channel activity in the endoplasmic reticulum.

J Biol Chem. 2008 Jun 6;283(23):15946-55. Epub 2008 Mar 31.

 

16. Effect of high molecular weight water-soluble chitosan on the trabecular bone and thickness in ovariectomized rats.

Immunopharmacol Immunotoxicol. 2007;29(3-4):439-49.

 

17. Estrogen attenuates cardiac ischemia-reperfusion injury via inhibition of calpain-mediated bid cleavage.

Arch Pharm Res. 2007 Oct;30(10):1225-35.

 

18. Functional regulation of hepatic cytochrome p450 enzymes by physicochemical properties of phospholipids in biological membranes.

Curr Protein Pept Sci. 2007 Oct;8(5):496-505. Review.

 

19. Differential effects of superoxide radical on the action potentials in ventricular muscles, Purkinje fibers and atrial muscles in the heart of different aged rats.

Arch Pharm Res. 2007 Sep;30(9):1088-95.

 

20. Effects of triglyceride on ER stress and insulin resistance.

Biochem Biophys Res Commun. 2007 Nov 9;363(1):140-5. Epub 2007 Sep 4.

 

21. Interleukin-6 and cyclic AMP stimulate release of cathepsin B in human osteoblasts.

Immunopharmacol Immunotoxicol. 2007;29(2):155-72.

 

22. Characterization of cytochrome P450s mediating ipriflavone metabolism in human liver microsomes.

.Xenobiotica. 2007 Mar;37(3):246-59.

 

23. Bax inhibitor-1 regulates endoplasmic reticulum stress-associated reactive oxygen species and heme oxygenase-1 expression.

J Biol Chem. 2007 Jul 27;282(30):21618-28. Epub 2007 May 24.

 

24. Mammalian dap3 is an essential gene required for mitochondrial homeostasis in vivo and contributing to the extrinsic pathway for apoptosis.

FASEB J. 2007 Jan;21(1):188-96. Epub 2006 Nov 29.

 

25. Plantainoside D protects adriamycin-induced apoptosis in H9c2 cardiac muscle cells via the inhibition of ROS generation and NF-kappaB activation.

Life Sci. 2007 Jan 2;80(4):314-23. Epub 2006 Sep 26.

 

26. Effect of green tea consumption on endothelial function and circulating endothelial progenitor cells in chronic smokers.

Circ J. 2006 Aug;70(8):1052-7.

 

27. Hydrogen sulfide inhibits nitric oxide production and nuclear factor-kappaB via heme oxygenase-1 expression in RAW264.7 macrophages stimulated with lipopolysaccharide.

Free Radic Biol Med. 2006 Jul 1;41(1):106-19. Epub 2006 Apr 25.

 

28. Protective effect of calceolarioside on adriamycin-induced cardiomyocyte toxicity.

Eur J Pharmacol. 2006 Jul 10;541(1-2):24-32. Epub 2006 May 9.

 

29. Mechanism of cyclosporine-induced overgrowth in gingiva.

J Dent Res. 2006 Jun;85(6):515-9.

30. Bax Inhibitor-1 Is a pH-dependent regulator of Ca2+ channel activity in the endoplasmic reticulum.

        J Biol Chem. 2008 Jun 6;283(23):15946-55.

 

31. Bax Inhibitor-1 Regulates Endoplasmic Reticulum Stress-associated Reactive Oxygen Species and Heme Oxygenase-1 Expression.

        J Biol Chem . 2007 Jul 27;282(30):21618-28.

 

32. Mammalian dap3 is an essential gene required for mitochondrial homeostasis in vivo and contributing to the extrinsic pathway for apoptosis.

        FASEB J . 2007 Jan;21(1):188-96.

 

33. Plantainoside D protects adriamycin-induced apoptosis in H9c2 cardiac muscle cells via the inhibition of ROS generation and NF-kappaB activation.

        Life Sci . 2007 Jan 2;80(4):314-23.

 

34. Hydrogen sulfide inhibits nitric oxide production and nuclear factor-kappaB via heme oxygenase-1 expression in RAW264.7 macrophages stimulated with lipopolysaccharide.

         Free Radic Biol Med . 2006 Jul 1;41(1):106-19.

 

35. Protective effect of calceolarioside on adriamycin-induced cardiomyocyte toxicity.

         Eur J Pharmacol . 2006 Jul 10;541(1-2):24-32.

 

36. Mechanism of cyclosporine-induced overgrowth in gingiva.

          J Dent Res. 2006 Jun;85(6):515-9.

 

37. Catalase protects cardiomyocytes via its inhibition of nitric oxide synthesis.

Nitric Oxide . 2006 May;14(3):189-99. Epub 2006 Jan 5.

 

38. Carbon monoxide and nitric oxide protect against tumor necrosis factor-alpha-induced apoptosis in osteoblasts: HO-1 is necessary to mediate the protection.

          Clin Chim Acta . 2006 Mar;365(1-2):270-8. Epub 2005 Oct 19.

 

39. Inhibitory effects of rosmarinic acid on adriamycin-induced apoptosis in H9c2 cardiac muscle cells by inhibiting reactive oxygen species and the activations of c-Jun N-terminal kinase and extracellular signal-regulated kinase.

          Biochem Pharmacol . 2005 Oct 1;70(7):1066-78.

 

40. BI-1 regulates an apoptosis pathway linked to endoplasmic reticulum stress.

          Mol Cell . 2004 Aug 13;15(3):355-66.

 

41. Evolutionarily conserved cytoprotection provided by Bax Inhibitor-1 homologs from animals, plants, and yeast.

         Gene. 2003 Dec 24;323:101-13.

 

42. Blockade of the p38 mitogen-activated protein kinase pathway inhibits inducible nitric oxide synthase and interleukin-6 expression in MC3T3E-1 osteoblasts.

          Pharmacol Res . 2001 Mar;43(3):275-83.

 

43. The p38 mitogen-activated protein kinase pathway regulates interleukin-6 synthesis in response to tumor necrosis factor in osteoblasts.

          Bone. 2001 Jan;28(1):45-53.

 

44. Dexamethasone suppresses tumor necrosis factor-alpha-induced apoptosis in osteoblasts: possible role for ceramide.

         Endocrinology. 2000 Aug;141(8):2904-13.

 

45. Signal transduction of thapsigargin-induced apoptosis in osteoblast.

          Bone. 1999 Oct;25(4):453-8.

 

46. Nitric oxide is a regulator of bone remodelling.

          J Pharm Pharmacol. 1997 Sep;49(9):897-902.